MSF Access

20/11/2025

🦠 By 2050, AMR is estimated to contribute to 8.2 million deaths worldwide.

For people living in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials is limited, the impact of AMR is more severe.

We’re addressing AMR through dedicated prevention, detection, and response efforts across more than 20 countries, but there must be an increased global response.

Improving access to microbiology labs 🔬 & lifesaving medicines 💊 in places with the greatest needs is essential.

19/11/2025

AMR, FTAs, TB, do you know what these acronyms mean, and what they have to do with access to health products?

If you're curious, read our latest newsletter, and then sign up for more access content!

Acronyms and global health often seem to go together. On the one hand, abbreviations like acronyms can be useful when you need to have a quick and easy way to talk about a complicated topic, especially one with a very long name.On the other hand, acronyms and jargon can feel a bit like barriers to e...

18/11/2025

SAVE THE DATE & REGISTER!

As part of World AMR Awareness Week, the AMR Multi-Stakeholder Partnership Platform and Médecins Sans Frontières (MSF) invite you to join an important dialogue:

Antimicrobial resistance in conflict-affected settings: field realities, operational challenges & policy recommendations

📅 Thursday, 20 November 2025
🕐 13:30 – 15:00 CET
💻 Virtual

Antimicrobial resistance (AMR) is one of the most significant global health threats of our time, and its impact is even more severe in fragile and conflict-affected settings, where access to infection prevention, diagnostics, and antimicrobials, is limited.

This dialogue will bring together experts and field practitioners to explore the intersection between conflict, fragility, and AMR, and to identify actionable policy recommendations for humanitarian and health actors.

🔗 Register here: https://fao.zoom.us/webinar/register/WN_NHOhABxPSi-Ia-TAS5XE8Q #/registration

14/11/2025

This World Diabetes Day, we’re calling for insulin pens – and all diabetes management tools – to be affordable and available for all.

Learn more about why this is important from Lecritia, Sana, and Ghassan, who share how their lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred.

https://msfaccess.org/what-it-means-lose-access-diabetes-care-three-stories-people-living-diabetes-around-world

12/11/2025

Today World Health Organization (WHO) released their 2025 report, and figures remain unacceptable: 1.2 million children and young adolescents fell ill in 2024, and a staggering 43% were never diagnosed and thus missed lifesaving treatment. Act now to close the deadly gap!

https://msfaccess.org/msf-responds-whos-annual-global-tb-report-governments-and-donors-must-close-deadly-gap-diagnosing

07/11/2025

Half of children and young adolescents with tuberculosis are not diagnosed and therefore do not receive lifesaving treatment… but why?

Take a look at the causes of this deadly gap, which we’ll be discussing in next week’s panel discussion (link in comments).

Tuberculosis (TB) remains the world’s deadliest infectious disease, despite being curable. In 2023, an estimated 1.3 million children and young adolescents f...

27/10/2025

Every child with TB deserves a healthy childhood. Yet in 2023, 1.25M fell ill with TB and nearly half were never diagnosed, thus never treated.

Join our webinar moderated by John Green where survivors and treatment providers will discuss how to close these deadly gaps.

➡️ https://www.youtube.com/watch?v=XBqQUT1hzgY

15/10/2025

At a panel discussion yesterday in Brussels, we urged policymakers, parliamentarians, regulatory agencies, and procurement bodies in the EU and the European Economic Area to take urgent steps to bridge the gap in accessing tuberculosis treatment in the region.

MSF first witnessed the systemic gaps in access to WHO-recommended treatments in 2022 when we launched a response in Poland to assist Ukrainian refugees and other migrants in accessing tuberculosis treatment.

A TB survivor shared her experience. Olga*, a person living with DR-TB in Warsaw, was started on the all-oral, six-month DR-TB regimen as recommended by the World Health Organization (WHO) to replace the previous DR-TB treatment regimen which was less effective and more toxic.

In the past 3 years, Poland has taken steps to improve TB treatment access by aligning national policies with WHO recommendations. But, many EU & EEA countries have not updated their guidelines and continue to grapple with barriers in accessing effective medicines and treatment.

Read more: https://msfaccess.org/msf-urges-eu-and-eea-put-tb-back-health-agenda

08/10/2025

Although tuberculosis is both preventable and curable, people with tuberculosis across Europe continue to face unnecessary suffering due to limited access to effective treatment and prevention medicines. Drawing on findings from our recent Technical Brief “Bridging the Gap: Securing Access to Essential TB Medicines in the EU and EEA”, we will hold a panel discussion on 14 October to discuss key barriers to access and explore the role that different actors can play in improving the availability and affordability of TB medicines. The discussion will address how to streamline regulatory pathways and strengthen cooperation between EU Member States, including through joint procurement and stockpiling.

Register 👉 https://us06web.zoom.us/webinar/register/WN_mdxDhP2TQZS92GVD5O6t-Q
Read the brief 👉 https://msfaccess.org/bridging-gap-securing-access-essential-tb-medicines-eu-and-eea

24/09/2025

Scientists who discovered over 100 years ago envisioned a world where everyone could access diabetes treatment.

And yet, diabetes treatment is too often unavailable or unaffordable.

Learn more ⬇️

17/09/2025

Even with access to the best tools, technology, and treatment, managing diabetes is complicated.

What happens when people face challenges accessing the diabetes care they need due to corporate decisions, displacement, or conflict?

Hear from Lecritia, Sana, and Ghassan, whose lives were impacted when they had to manage their diabetes without access to the medical tools they needed and preferred.

Managing diabetes is complicated. Even with access to the best tools and technology, it requires constant blood sugar level monitoring and daily treatment in the form of medication or insulin.

13/08/2025

The public health goals in low- and middle-income countries (LMICs) cannot be achieved without effective, accessible, and affordable tools which are fit for the environment of these countries.

Join us for a hybrid event at Tokyo International Conference on African Development where we will discuss challenges & solutions for accessing diagnostics in Africa, feature MSF field innovations and explore collaborations with Japan.

Date: 21 August 2025 (Thursday)
Time: 18:00-19:30 (Japan Time)
Venue: PACIFICO Yokohama & Zoom Webinar
Language: English
Registration: Pre-registration is required for virtual attendance. Register at https://www.msf.or.jp/event/detail/20250821.html